Flagstar Financial
FLG
$10.16
+0.20%
Flagstar Financial (formerly New York Community Bancorp) is a regional bank holding company operating roughly 340 branches across ten states, with concentrated footprints in the New York/New Jersey metro area, the upper Midwest, and growth markets in Florida and the West Coast, offering consumer and commercial banking, mortgage lending, and wealth management to individuals, small businesses, and corporations. The bank occupies a distinctive position as a multi-family and rent-regulated commercial real estate lender that pivoted toward a diversified commercial banking model following its 2024 acquisition of the former Signature Bank assets and a subsequent recapitalization led by a private equity consortium. The investor narrative is dominated by a credibility-restoration and turnaround story: after consecutive quarterly losses through mid-2025 tied to credit provisioning and CRE concentration concerns, the company has returned to modest profitability, and the debate now centers on whether margin recovery, deposit stability, and asset-quality normalization can be sustained. Recent headlines have skewed cautious, with options-market commentary flagging elevated implied volatility and falling earnings estimates, while sell-side firms have selectively upgraded (Morgan Stanley to Overweight in September 2026, TD Cowen to Buy in July) even as the stock has sold off sharply into October.…
FLG
Flagstar Financial
$10.16
Related headlines
Investment Opinion: Should I buy FLG Today?
Rating: Hold with a speculative-recovery bias. The core thesis is that FLG is a credible but unproven turnaround trading at 0.642x book and 9.33x forward earnings, where the 17-analyst 'buy' consensus and $15.29 average target (+47.3% upside) reflect a recovery that has begun (Q2 2026 net income of $34 million versus -$70 million a year earlier) but is not yet confirmed by revenue trends. The stock is not a Buy at $10.38 while it sits 0.8% above its 52-week low in an accelerating downtrend with falling estimates; it is not a Sell either, given the deep discount to book and the absence of any analyst target below the current price.
Supporting evidence is mixed but leans toward patient accumulation. On valuation, 0.642x P/B and 9.33x forward PE sit below the 0.9-1.1x book and 10-12x forward earnings typical of regional-bank peers, a 20-25% discount. On profitability, gross margin expanded from 35.4% to 47.3% year-over-year and operating margin turned positive at 4.56%, though trailing net margin of -3.77% and ROE of -2.17% show the recovery is early. Revenue remains the weak link at -13.77% year-over-year, and free cash flow TTM of $79 million is thin against a $5.23 billion market cap. The implied +47.3% upside to the average target is unusually wide and reflects sell-side conviction that has not yet been marked down to the October price.
Key risks that could invalidate the thesis are a renewed CRE credit event, a further leg down in revenue, and estimate cuts that render the 9.33x forward multiple illusory. The rating would upgrade to Buy if the stock stabilizes above the $11.44 prior close with Q3 2026 revenue growth turning positive or net margin holding above 3%, or if P/B falls below 0.55x without a corresponding deterioration in credit metrics. It would downgrade to Sell if the stock breaks decisively below $10.295 with Q3 earnings showing renewed provisioning or a revenue decline steeper than 15%. Verdict: undervalued relative to book and peers, but fairly-to-fully valued relative to the risk that the forward earnings recovery slips — a value opportunity contingent on execution, not a bargain to chase.
Sign up to view all
FLG 12-Month Price Forecast
The forward-looking view is genuinely balanced: the valuation is cheap on book and forward earnings, and the profitability inflection is real, but the revenue trajectory and technical picture argue against chasing the stock at $10.38. The 47.3% upside to the $15.29 average target is only credible if the $1.664 forward EPS holds, and falling estimates plus a 10.0-day short ratio suggest the market is not yet convinced. I would upgrade to bullish on evidence of revenue stabilization above $1.05 billion with net margin sustained above 3%, or on a decisive reclaim of the $11.44 prior close. I would downgrade to bearish if the stock breaks the $10.295 low with Q3 provisioning above Q2 levels or a forward EPS cut below $1.487.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Flagstar Financial's 12-month outlook, with a consensus price target around $13.53 and implied upside of +33.2% versus the current price.
Average Target
$13.53
0 analysts
Implied Upside
+33.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$11 - $16
Analyst target range
Coverage is robust with 17 analysts, and sentiment leans bullish: the consensus recommendation is "buy" with a mean rating of 1.889 (where 1 is strong buy and 5 is strong sell), and the average target price of $15.29 implies +47.3% upside from the current $10.38. That is an unusually wide gap between price and target, and it reflects a sell-side community that has largely held its ground through the decline — Morgan Stanley upgraded to Overweight on September 8, 2026 and reiterated on September 28, TD Cowen moved to Buy from Hold on July 6, and DA Davidson, Cantor Fitzgerald, and Barclays all maintain Buy/Overweight ratings, while JP Morgan and RBC remain Neutral/Sector Perform.
The target range of $13.00 to $18.00 is wide relative to the $10.38 price, signaling genuine disagreement about the earnings recovery path. The $18.00 high target implies roughly 1.1x book and a successful normalization of credit costs with forward EPS near or above the $1.664 consensus, while the $13.00 low target still assumes +25% upside and prices in a slower, margin-compressed recovery rather than a bear case — notably, no analyst target sits below the current price, which is either a strong conviction signal or a sign that estimates have not yet been marked down to reflect the October selloff. With the stock down 15.6% in a month and estimates reportedly falling, the risk is that targets follow price lower; the wide spread and heavy 10-day short ratio mean realized volatility will likely exceed what the bullish consensus implies.
Bulls vs Bears: FLG Investment Factors
The bear case currently carries stronger near-term evidence: FLG is in an accelerating downtrend at the bottom of its 52-week range, revenue is contracting 13.8% year-over-year, and trailing profitability remains negative on a TTM basis. The bull case rests almost entirely on the forward earnings recovery — a 9.33x forward PE and 0.642x P/B are only cheap if the $1.664 consensus EPS is delivered, and falling estimates suggest that conviction is eroding. The single most important tension is whether the Q2 2026 inflection (net income of $34 million, gross margin of 47.3%) represents a durable turn or a temporary reprieve before further credit provisioning; resolution of that question — most likely via the next two earnings reports — will determine whether the discount to book closes or widens.
Bullish
- Deep discount to book value: FLG trades at 0.642x price-to-book, roughly a 35% discount to tangible book and well below the 0.90x P/B reached in Q4 2023. For a bank that has returned to profitability, this discount embeds substantial skepticism that could unwind if credit costs normalize.
- Earnings inflection already underway: Net income swung from -$70 million in Q2 2025 to +$34 million in Q2 2026, with gross margin expanding from 35.4% to 47.3% and operating margin turning positive at 4.56%. The trajectory is clearly improving even if the absolute level remains modest.
- Analyst consensus sees 47% upside: 17 analysts carry a 'buy' consensus (mean rating 1.889) with an average target of $15.29, implying +47.3% upside from $10.38. Notably, the lowest target of $13.00 still sits 25% above the current price, suggesting the sell-side views the selloff as overdone.
- Forward PE of 9.33x is cheap if met: Consensus forward EPS of $1.664 against a $10.38 price yields a 9.33x forward multiple, below the 10-12x typical regional-bank peer range. If the recovery holds, the stock is priced for disappointment that may not materialize.
Bearish
- Revenue contracting 13.8% year-over-year: Q2 2026 revenue of $1.052 billion fell 13.77% from $1.220 billion a year earlier, extending a slide from $1.433 billion in Q4 2024. Consensus forward revenue of $3.00 billion versus a ~$4.2 billion trailing run-rate implies continued shrinkage, undermining any re-rating case.
- Falling-knife technical breakdown: FLG sits just 0.8% above its 52-week low of $10.295 after a -9.27% single-session collapse, with a -32.42% max drawdown and -32.47% relative strength versus the S&P over six months. Momentum is accelerating downward (-15.6% in one month vs -25.1% in three), with no positive divergence.
- Thin profitability and weak capital returns: Trailing net margin is -3.77% and ROE is -2.17%, with ROA of just 0.05% — far below the high-single-digit ROE peers generate. Interest coverage of 0.09x on $536 million of quarterly interest expense leaves earnings highly sensitive to funding costs.
- Elevated leverage and volatile cash flow: Debt-to-equity of 1.496 and a 57.3% debt-to-capitalization ratio are high for a regional bank, while free cash flow swung from -$216 million in Q4 2025 to +$215 million in Q2 2026. Cash fell from $7.085 billion to $5.18 billion as the bank funded investment purchases and debt repayment.
FLG Technical Analysis
FLG is in a clear, sustained downtrend, with the current price of $10.38 sitting just 0.8% above its 52-week low of $10.295 and roughly 32.8% below its 52-week high of $15.44 — effectively trading at the very bottom of its 52-week range. The 1-year change of -10.21% understates the severity of the move, as the stock spent mid-2026 near $15 before a persistent slide; the -32.42% max drawdown confirms this is a falling-knife setup rather than a benign pullback, and relative strength versus SPY is deeply negative at -23.34% over one year. The most recent session saw a -9.27% single-day collapse from $11.44 to $10.38 on elevated volume of 24.2 million shares, a capitulation-style move that demands caution.
Short-term momentum is decisively negative and accelerating to the downside: the 1-month change of -15.61% is worse than the 3-month change of -25.05%, which is itself worse than the 6-month change of -26.02%, indicating the decline has steepened rather than stabilized. Relative strength versus the S&P 500 is negative across every window (-14.59% over 1 month, -27.90% over 3 months, -32.47% over 6 months), meaning FLG is underperforming a market that itself is roughly flat to modestly positive — a hallmark of idiosyncratic deterioration, not sector beta. There is no positive divergence to point to; the 1-month trend confirms rather than contradicts the 1-year downtrend, and the short ratio of 10.0 days signals heavy short interest that could amplify either a squeeze or further liquidation.
Key technical levels are tightly defined: support sits at the 52-week low of $10.295, and with the stock at $10.38, a decisive break below that level would open a fresh leg lower with no historical floor in the provided data. Resistance is layered at the $11.44 prior close and the $15.44 52-week high, with the $13.00 analyst low target acting as an intermediate magnet if a reversal develops. Beta of 1.052 means FLG is only about 5% more volatile than the market on a smoothed basis, but the -9.27% single-day drop and 10-day short ratio reveal event-driven tail risk far exceeding that beta suggests — position sizing should account for gap risk, not just daily volatility.
Beta
1.05
1.05x market volatility
Max Drawdown
-34.0%
Largest decline past year
52-Week Range
$10-$15
Price range past year
Annual Return
-13.5%
Cumulative gain past year
| Period | FLG Return | S&P 500 |
|---|---|---|
| 1m | -15.6% | +0.9% |
| 3m | -28.7% | +4.1% |
| 6m | -27.1% | +7.2% |
| 1y | -13.5% | +12.4% |
| ytd | -19.0% | +13.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FLG Fundamental Analysis
Revenue is contracting: Q2 2026 revenue of $1.052 billion fell 13.77% year-over-year, extending a multi-quarter slide from $1.244 billion in Q1 2025 and $1.433 billion in Q4 2024, reflecting balance-sheet shrinkage and deliberate loan runoff. Sequentially, revenue has been roughly flat at $1.039 billion (Q1 2026) and $1.052 billion (Q2 2026) after bottoming near $1.114 billion in Q4 2025, suggesting the contraction may be stabilizing but not yet reversing. The key tension for the investment case is that consensus models $3.00 billion in forward revenue against a trailing run-rate near $4.2 billion annualized — a gap that implies either further shrinkage or a definitional mismatch, and either way the growth trajectory does not support a re-rating without visible inflection.
Profitability has inflected from deeply negative to marginally positive: net income was $34 million in Q2 2026 versus a -$70 million loss in Q2 2025, with EPS of $0.0624 (diluted $0.0549) and a net margin of 3.23%, up from -5.74% a year earlier. Gross margin has expanded steadily from 35.4% in Q2 2025 to 47.3% in Q2 2026, and operating margin turned positive at 4.56% from -6.64%, but the trailing twelve-month picture remains weak with a -3.77% net margin and -4.22% operating margin. Interest expense of $536 million against interest income of $976 million leaves a thin spread, and the 0.09x interest coverage ratio underscores how sensitive earnings are to funding costs — this is a bank still climbing out of a hole, not one compounding at scale.
Balance-sheet risk remains the central concern: debt-to-equity of 1.496 and a total-debt-to-capitalization ratio of 57.3% are elevated for a regional bank, while ROE of -2.17% and ROA of just 0.05% signal poor capital productivity. Free cash flow is volatile — $215 million in Q2 2026 and $79 million TTM, but -$153 million in Q1 2026 and -$216 million in Q4 2025 — and the current ratio of 0.537 reflects the bank's liability-heavy structure rather than a liquidity crisis, though it offers little cushion. Cash fell from $7.085 billion to $5.18 billion in Q2 2026 as the bank deployed $3.375 billion into investment purchases and repaid $250 million of debt, and with a PCF ratio of -9.79 and a modest 0.92% dividend yield, internal cash generation is not yet sufficient to fund growth without continued balance-sheet management.
Quarterly Revenue
$1.1B
2026-06
Revenue YoY Growth
-13.8%
YoY Comparison
Gross Margin
47.3%
Latest Quarter
Free Cash Flow
$79000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FLG Overvalued?
Because trailing net income is negative (EPS of -$0.034, trailing PE of -24.69x), the PE ratio is not a valid primary metric; I therefore lead with price-to-book (0.642x) and price-to-sales (1.114x) as the appropriate anchors for a bank in earnings recovery. The forward PE of 9.33x against consensus EPS of $1.664 implies the market expects a dramatic earnings rebound from the current $0.0624 quarterly run-rate, and the gap between the negative trailing PE and the 9.33x forward multiple is essentially the entire bull case — if the forward estimate is met, the stock is cheap; if it slips, the multiple is illusory.
Against a typical regional-bank peer set trading in the 10-12x forward earnings and 0.9-1.1x book range, FLG's 9.33x forward PE and 0.642x P/B represent a meaningful discount — roughly 20-25% below book and below the peer forward multiple — which the market is justifying with inferior profitability (ROE of -2.17% versus peers in the high single digits), elevated CRE concentration, and a 57.3% debt-to-capitalization ratio. The 1.114x PS ratio is harder to benchmark without a sector average in the provided data, but the negative EV/EBITDA of -337x and PCF of -9.79 confirm that cash-based and EBITDA-based multiples are unusable here. The discount looks like a value opportunity only if the forward EPS estimate of $1.664 proves durable; otherwise it is a value trap.
Historically, FLG's P/B has ranged from 0.28x (Q1 2024, the crisis trough) to 0.90x (Q4 2023), with the current 0.642x sitting in the lower-middle of that band and well below the 0.765x recorded as recently as Q2 2026. The PS ratio of 1.114x is near the low end of its multi-year range (which peaked above 13x in 2021 when the business mix was entirely different), while the historical PE of 59.9x in Q2 2026 versus the current negative trailing PE illustrates how unstable earnings-based metrics have been. The stock is not at a historical extreme cheapness like early 2024, but it is pricing in skepticism — the market is assigning roughly a 35% discount to book, consistent with unresolved credit and earnings-quality concerns rather than outright distress.
PE
-24.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 1x~11x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-337.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on a still-fragile earnings base. Trailing net margin is -3.77% and ROE is -2.17%, meaning the bank has not yet demonstrated it can earn its cost of capital; Q2 2026 net income of $34 million on $1.052 billion of revenue is a 3.23% margin that could be erased by a single quarter of elevated provisioning. Interest expense of $536 million against $976 million of interest income leaves a thin spread, and the 0.09x interest coverage ratio means funding-cost spikes flow almost directly to the bottom line. Free cash flow volatility (-$216 million in Q4 2025, -$153 million in Q1 2026, +$215 million in Q2 2026) and a cash balance that fell from $7.085 billion to $5.18 billion in one quarter underscore limited internal cushion, while debt-to-equity of 1.496 and a 57.3% debt-to-capitalization ratio leave little room for error.
Market and competitive risks are dominated by valuation compression and sector sentiment. At 0.642x P/B and 9.33x forward earnings, FLG already trades at a 20-25% discount to regional-bank peers, but that discount can widen if CRE credit concerns resurface — the bank's multi-family and rent-regulated lending concentration remains a structural overhang. Beta of 1.052 suggests only modest market correlation, yet the -9.27% single-day drop and 10.0-day short ratio reveal event-driven tail risk far exceeding beta; a sector rotation away from regional banks or a peer's credit surprise could trigger another leg down. Recent news flow is cautionary: options-market commentary in September 2026 flagged elevated implied volatility and falling earnings estimates with downside skew, and the stock's -32.47% six-month relative underperformance versus the S&P confirms idiosyncratic deterioration rather than broad sector weakness.
Worst-case scenario: a renewed CRE credit event or a disappointing Q3/Q4 earnings report that forces analysts to cut the $1.664 forward EPS estimate would invalidate the entire bull case, since the 9.33x forward multiple is the only valuation support. In that chain, the stock breaks the $10.295 52-week low with no historical floor in the provided data, and the $13.00 analyst low target becomes irrelevant as estimates reset lower. From the current $10.38, a break to the 52-week low implies roughly -0.8%, but a genuine credit-driven repricing toward the 0.28x P/B crisis trough of Q1 2024 would imply a far deeper loss — on the order of -55% from current levels. Even a moderate downside scenario to the $8-9 range (roughly -13% to -23%) is plausible if the October selloff extends and targets are marked down.
FAQ
Ranked by severity: first, credit risk from the multi-family and rent-regulated CRE concentration, which could force renewed provisioning and invalidate the $1.664 forward EPS estimate that underpins the 9.33x forward multiple. Second, financial leverage risk — debt-to-equity of 1.496, a 57.3% debt-to-capitalization ratio, and 0.09x interest coverage leave little cushion if funding costs rise. Third, revenue contraction risk, with Q2 2026 revenue down 13.77% year-over-year and consensus forward revenue of $3.00 billion implying further shrinkage from the ~$4.2 billion run-rate. Fourth, technical/momentum risk — the stock is 0.8% above its 52-week low with a 10.0-day short ratio and -32.47% six-month relative underperformance, meaning a break lower could accelerate.
The 12-month forecast has three scenarios: a 25% bull case targeting $15.29-$18.00 (average to high analyst target) if the $1.664 forward EPS is delivered and credit normalizes; a 50% base case targeting $11.50-$13.50 as the recovery proceeds unevenly and estimates drift toward the $13.00 low target; and a 25% bear case targeting $8.00-$10.295 if a CRE credit event breaks the 52-week low. The base case is most likely because quarterly net income has turned positive ($34 million in Q2 2026) but revenue is still contracting, so the market is likely to wait for confirmation rather than re-rate immediately. The key assumption behind the base case is that credit costs stay contained while revenue stabilizes near $1.05 billion per quarter.
FLG screens as undervalued on book value: 0.642x P/B is roughly a 35% discount to tangible book and below the 0.90x reached in Q4 2023, while the 9.33x forward PE sits below the 10-12x regional-bank peer range. However, the trailing PE of -24.69x is unusable because TTM EPS is -$0.034, and the negative EV/EBITDA of -337x and PCF of -9.79 confirm cash-based multiples are meaningless here. The market is paying a discount because it doubts the $1.664 forward EPS consensus — the gap between the negative trailing multiple and the 9.33x forward multiple is essentially the entire bull case. If the recovery is delivered, the stock is cheap; if estimates slip, the discount is deserved, making this a fairly-valued-to-undervalued stock contingent on execution.
From a risk/reward perspective, FLG offers an asymmetric setup only for investors who can tolerate volatility: the 47.3% upside to the $15.29 average target is large, but the stock sits just 0.8% above its $10.295 52-week low after a -9.27% single-day collapse. The valuation at 0.642x book and 9.33x forward earnings is genuinely cheap versus regional-bank peers at 0.9-1.1x book, but that discount exists because trailing ROE is -2.17% and revenue is contracting 13.77%. The biggest downside risk is a break below the 52-week low with renewed CRE provisioning, which could take the stock toward the 0.28x P/B crisis trough. It is a reasonable buy for patient, risk-tolerant investors building a position in tranches near the low, but not for those seeking near-term momentum or income.
FLG is better suited to long-term holding than short-term trading, but only for investors with high risk tolerance and a minimum two-to-three-year horizon. The turnaround from a -$70 million quarterly loss to +$34 million in net income is a multi-quarter process, and the 0.92% dividend yield offers little compensation while waiting; beta of 1.052 understates the event-driven gap risk revealed by the -9.27% single-day drop and 10.0-day short ratio. Short-term traders face a falling-knife setup at the 52-week low with no positive technical divergence, which is a poor risk/reward for momentum strategies. A suggested minimum holding period of 24-36 months allows time for credit normalization and margin recovery to validate the 9.33x forward multiple, with position sizing that accounts for a potential -55% drawdown to crisis-era book multiples.